PRRT2 and breast cancer: Interestingly, strong induction of promoter activity by PDBu, a potent activator of PKC (Figure 4b) was also inhibited by PD98059, suggesting an important role for the p42/p44 MAPK signalling pathway in controlling Brn-3b promoter activity in breast cancer cells through different upstream activators.